1 / 22

PDIG Summer 2011

Gain insights into NHS staff perspectives on medicine shortages, procurement challenges, and reactions to supply issues. Explore causes, estimated quantities, demand profiles, lead times, and supplier performance in the context of addressing shortages. Analyze risk assessments, financial implications, and the role of regulatory bodies in resolving procurement issues.

wholmstrom
Download Presentation

PDIG Summer 2011

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PDIGSummer 2011 Ian Allen Lead Category Manager DH Commercial Medicines Unit

  2. Supply Shortages – Solutions and not just excuses! NHS Perspective -What are the problems for procurement and other NHS staff? How is the NHS reacting to the lack of medicines?

  3. Supply Shortages – Solutions and not just excuses! NHS Perspective -What are the problems for procurement and other NHS staff? How is the NHS reacting to the lack of medicines?

  4. Shortages - causes • PDIG Family Fortunes • I asked a completely unrepresentative sample of industry representatives ……..

  5. What did our sample say?

  6. 1.Estimated quantities • Pharmex data

  7. 1.Estimated quantities: Px data

  8. 1.Estimated quantities • Pharmex data • Transition products – newly available generics

  9. 1.Estimated quantities: transition products

  10. 2. Changes in product demand profile • Number and history of published tenders • eMIT

  11. 2. Changes in product demand profile • Number and history of published tenders • eMIT • Pre-tender meetings – PMSG sub-group

  12. 3. Lead time • 12 weeks • 14 d. “off contract claim" period

  13. 4. A.N. Other out of stock • Ring-fence stock to “contracted” Regions • Dialogue with CMU

  14. 5. Production/supply chain problems • SCEP: 33% and 100% products • Risk assessment: worry about the hospital-only products • Role of MHRA • Role of DH MPIG • CMU and supplier performance

  15. So, with all of that effort what does the world look like?

  16. Problems for NHS staff No of suppliers on Mar 2010 issues return = 33 No of products on Mar 2010 issues return = 121 No of suppliers on Mar 2011 issues return = 36 No of products on Mar 2011 issues return = 216

  17. …. or more locally….

  18. Risk analysis: incorrectly applied or working?

  19. In financial terms (remember this does not include 14d. period)

  20. Problems for procurement?

More Related